Skip to main content
AXTA
NYSE Industrial Applications And Services

Axalta Cuts 2026 Guidance on Soft Europe Refinish; Merger Close Still Early 2027

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Chemical Stocks · Materials
Sentiment info
Negative
Importance info
7
Price
$33.61
Mkt Cap
$7.193B
52W Low
$24.937
52W High
$38.61
52W Position info
35% above low
Off High info
13% below high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

AXTA sits 35% above its 52-week low of $24.937.

Summary

Axalta's Q3 call transcript confirms a cut to 2026 guidance — adjusted EBITDA of $1.1B-$1.11B and EPS of about $2.45 — driven by weak European Refinish volumes and higher freight costs, while the AkzoNobel merger stays on track to close in early 2027.


Key Events · Earnings and Guidance · AXTA

  • 2026 Guidance Cut on Soft Q3

    Full-year adjusted EBITDA is now $1.1B-$1.11B and adjusted diluted EPS about $2.45; Q4 adjusted EBITDA is guided to $254M-$264M and Q4 EPS to about $0.55.

  • Q4 Sales Now Roughly Flat

    Management now expects Q4 net sales approximately flat year-over-year versus up 3% previously, citing softer European Refinish volumes and macro uncertainty.

  • Free Cash Flow Guide Lowered

    Full-year free cash flow is expected at approximately $450M including higher merger-related costs, versus greater than $500M excluding deal costs.

  • Merger Clearances at Two-Thirds

    Regulatory clearance is secured in two-thirds of required jurisdictions, with only the AkzoNobel European Refinish and Axalta North America Building Products divestitures as remedies; close expected early 2027.


Analysis · AXTA · Industrial Applications And Services

The Q3 numbers were already out today, but the call transcript carries the formal guidance cut: full-year adjusted EBITDA is now $1.1B-$1.11B and adjusted EPS about $2.45, with Q4 sales roughly flat instead of up 3%. The miss is concentrated in European Refinish, where distributors paused restocking, plus freight costs up over 15% year-on-year. Against that, the AkzoNobel merger remains on track — clearance in two-thirds of required jurisdictions, only two divestitures as remedies, and a close expected in early 2027 — so the earnings softness is a near-term drag on a deal story rather than a change to the deal itself.

How filings like this one have moved

In the 30 days to Oct 29, 2026, 30.9% of the 1649 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.02%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, AXTA was trading at $33.61 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $7.2B. The 52-week trading range was $24.94 to $38.61. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

AXTA - Latest Insights

AXTA
Oct 29, 2026, 5:16 PM EDT
Filing Type: 425
Importance Score:
7
AXTA
Oct 29, 2026, 3:12 PM EDT
Filing Type: 10-Q
Importance Score:
7
AXTA
Oct 29, 2026, 1:25 PM EDT
Source: Reuters
Importance Score:
7
AXTA
Oct 29, 2026, 7:10 AM EDT
Filing Type: 8-K
Importance Score:
7
AXTA
Oct 29, 2026, 6:17 AM EDT
Source: Dow Jones Newswires
Importance Score:
7